Clinical Trials Directory

Trials / Completed

CompletedNCT01168518

An Observational Study on the Sorin Group New Brady Leads XFine and Beflex

Performance of the New Generation of Sorin Group Brady Leads In a Normal Hospital Practice

Status
Completed
Phase
Study type
Observational
Enrollment
2,254 (actual)
Sponsor
LivaNova · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This observational study is a non-interventional multi-centre, prospective study. The aim of the study is to evaluate the Sorin Group new passive- and active- fixation pacing leads. We plan to assess the acute and short term lead dislodgment rate (within the first three months following implantation) correlated with the type of lead (active- or passive- fixation). Further, we are collecting data related to leads handling and leads electrical performances

Detailed description

The primary objective of this observational study is to assess the acute rate of dislodgment of the new Sorin group range of active- and passive- fixation leads up to 3 months following implant. Assessment of electrical performances (pacing threshold, sensing amplitude, impedance) of the leads at implant and during follow-up.

Conditions

Timeline

Start date
2008-07-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2010-07-23
Last updated
2014-09-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01168518. Inclusion in this directory is not an endorsement.

An Observational Study on the Sorin Group New Brady Leads XFine and Beflex (NCT01168518) · Clinical Trials Directory